| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/21/2002 | CA2037664C Monoclonal antibody against complexed and noncomplexed complexing agents for removing heavy metals from aqueous solutions and for analysis |
| 05/21/2002 | CA1341361C Human erythropoietin gene: high level expression in stably transfected mammalian cells |
| 05/16/2002 | WO2002039123A1 Kit and method for detecting the esm-1 protein |
| 05/16/2002 | WO2002039120A1 A method for identifying the proteome of cells using an antibody library microarray |
| 05/16/2002 | WO2002038805A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 05/16/2002 | WO2002038797A2 Modulators of bruton's tyrosine kinase, their identification and use |
| 05/16/2002 | WO2002038790A1 Process for producing germ extract |
| 05/16/2002 | WO2002038778A1 Differentiation-inducing substances |
| 05/16/2002 | WO2002038774A2 Bacterial phytases and method for producing same |
| 05/16/2002 | WO2002038766A2 Human tumor necrosis factor receptor |
| 05/16/2002 | WO2002038755A1 Circular extra-chromosomal dna elements |
| 05/16/2002 | WO2002038750A1 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038741A1 Cell reprogramming |
| 05/16/2002 | WO2002038736A2 Methods for regulating plant gaba production |
| 05/16/2002 | WO2002038735A2 Two chamber cell culture vessel |
| 05/16/2002 | WO2002038732A2 Human testis specific serine/threonine kinase |
| 05/16/2002 | WO2002038730A2 Novel human potassium channel beta subunit |
| 05/16/2002 | WO2002038726A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/16/2002 | WO2002038609A2 Apolipoprotein conjugates |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038601A2 Foggy |
| 05/16/2002 | WO2002038600A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | WO2002038588A2 Putrescine-n-methyltransferase promoter |
| 05/16/2002 | WO2002038162A1 MODIFIED FACTOR VIIa |
| 05/16/2002 | WO2002038108A2 Methods of treating disorders related to apoe |
| 05/16/2002 | WO2002037968A1 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells |
| 05/16/2002 | WO2002037967A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 05/16/2002 | WO2002020823A3 Methods and compositions for visualizing and interfering with chromosomal tethering of extrachromosomal molecules |
| 05/16/2002 | WO2002018448A3 Percarboxylated polysaccharides, and a process for their preparation |
| 05/16/2002 | WO2002012539A3 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/16/2002 | WO2002006502A3 Adenovirus vectors comprising introns |
| 05/16/2002 | WO2002000899A3 Heterologous gene expression in plants |
| 05/16/2002 | WO2001096593A3 Novel motor proteins and methods for their use |
| 05/16/2002 | WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/16/2002 | WO2001090313A3 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS |
| 05/16/2002 | WO2001088182A3 Lipid bilayer array methods and devices |
| 05/16/2002 | WO2001088105A3 Production of dendritic cells from bone-marrow stem cells |
| 05/16/2002 | WO2001088098A3 Fertilization of aged oocytes |
| 05/16/2002 | WO2001085913A3 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 05/16/2002 | WO2001081405A3 Methods and compositions for the prevention and treatment of anemia |
| 05/16/2002 | WO2001080810A3 Chondroitin synthase gene and methods of making and using same |
| 05/16/2002 | WO2001079518A3 Codon optimisation for expression in retrovirus packaging cells |
| 05/16/2002 | WO2001079492A3 Lipid binding protein 3 |
| 05/16/2002 | WO2001077171A3 Soluble zalpha11 cytokine receptors |
| 05/16/2002 | WO2001075109A3 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 05/16/2002 | WO2001074857A3 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 05/16/2002 | WO2001058526A3 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 05/16/2002 | WO2001048163A3 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 05/16/2002 | WO2001047959A3 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | WO2001032685A8 Gene expression directed by a super-psa promoter |
| 05/16/2002 | WO2001032128A9 Human chemokine beta-13 |
| 05/16/2002 | WO2001029255A3 Diagnostic test for cephalic pain |
| 05/16/2002 | US20020059653 Modulating protein complex formation in cells; obtain sample tissue, incubate with acetylcholine esterase, expose to modulator, monitor sample for complex formation |
| 05/16/2002 | US20020059652 Detecting modulators of liver cell propagation, cell differentiation and lymphocyte activity; obtain modulator, incubate with indicator, mix with culture monitor culture for adjustment in activity |
| 05/16/2002 | US20020058983 Methods for implanting cells |
| 05/16/2002 | US20020058797 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein |
| 05/16/2002 | US20020058718 Porous composite materials |
| 05/16/2002 | US20020058636 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 05/16/2002 | US20020058619 Ligand for vascular endothelial growth factor receptor |
| 05/16/2002 | US20020058613 Modulating the expression or bioactivity of a bcl family member in a neural cell such that axonal growth occurs. |
| 05/16/2002 | US20020058339 Tissue for maintaining fertilzed eggs |
| 05/16/2002 | US20020058338 Propagating hematopietic cells; obtain cells, inoculate nutrient broth, monitor propagation of cells, recover hematopietic cells |
| 05/16/2002 | US20020058337 Novel epidermis/dermis equivalents and aged skin equivalents shaped therefrom |
| 05/16/2002 | US20020058336 Controlling cell binding; obtain target cell, incubate with substrate, monitor cell binding |
| 05/16/2002 | US20020058327 Materials and methods for the enhancement of effective root nodulation in legumes |
| 05/16/2002 | US20020058325 Recombinant AAV packaging systems |
| 05/16/2002 | US20020058322 DNA molecules encoding fibrinolytically active polypeptide |
| 05/16/2002 | US20020058321 Method of determining the activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase and 1-deoxy-D-xylulose-5-phosphate synthase |
| 05/16/2002 | US20020058318 Gels for encapsulation of biological materials |
| 05/16/2002 | US20020058317 Process for the fusion of dendritic cells with abnormal tissue cells, in particular tumor cells and media for such a process |
| 05/16/2002 | US20020058309 Nucleotide sequences for use in the treatment of nervous system disorders and neuronal damage |
| 05/16/2002 | US20020058290 Stable genetically engineered muscle cell; for use in the generation of modulators for treatment of cancer, metabolic defects, cachexia and aging defects |
| 05/16/2002 | US20020058289 Novel antibody compositions for preparing enriched mesenchymal progenitor preparations |
| 05/16/2002 | US20020058288 Compound for use in the detection and prevention of parasitic infection of humans |
| 05/16/2002 | US20020058284 Methods and compositions for treating macrophage-mediated diseases |
| 05/16/2002 | US20020058264 Human regulatory molecules |
| 05/16/2002 | US20020058253 High affinity TCR proteins and methods |
| 05/16/2002 | US20020058249 Dna shuffling to produce herbicide selective crops |
| 05/16/2002 | US20020058241 Antibody for use in the treatment of prostate cancer |
| 05/16/2002 | US20020058044 LVPs associated with human immunoglobulins having a density of less than 1.063 g/ml. |
| 05/16/2002 | US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 05/16/2002 | US20020058036 Novel fibroblast growth factor and nucleic acids encoding same |
| 05/16/2002 | US20020058034 Treating or ameliorating an autoimmune condition, an allergic reaction or asthma |
| 05/16/2002 | US20020058024 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 05/16/2002 | US20020058019 Simultaneous stimulation and concentration of cells |
| 05/16/2002 | DE10115439A1 Inducing differentiation of immature dendritic cells, for use in vaccines for immunotherapy of cancer, comprises ex vivo treatment with heat-shock protein 70 |
| 05/16/2002 | CA2428453A1 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | CA2428368A1 Kit and method for detecting the esm-1 protein |
| 05/16/2002 | CA2428282A1 Methods for regulating plant gaba production |
| 05/16/2002 | CA2428242A1 Human tumor necrosis factor receptor |
| 05/16/2002 | CA2428241A1 Novel human potassium channel beta subunit |
| 05/16/2002 | CA2428161A1 Substances causing differentiation |
| 05/16/2002 | CA2428114A1 Apolipoprotein analogues |
| 05/16/2002 | CA2427825A1 Putrescine-n-methyltransferase promoter |
| 05/16/2002 | CA2426508A1 Modulators of bruton's tyrosine kinase and bruton's tyrosine kinase intermediates and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2426030A1 Methods of treating disorders related to apoe |